About Relajet
Relajet is a startup. Brouky classifies it under Healthcare & Life Sciences.
Relajet develops AI-based speech enhancement technology for hearing devices, focusing on on-device processing to improve speech clarity in hearing aids and related assistive audio hardware. Their solution is implemented on Arm-based platforms for low-power embedded inference.
Explore Relajet's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.